Per ulteriori informazioni selezionare i riferimenti di interesse.
Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9
Gene therapy for haemophilia: the end of a 'royal pathology' in the third millennium?
Gene therapy: a 2001 perspective
Applications of genetic engineering in veterinary medicine
ADVANCED DRUG DELIVERY REVIEWS
Preclinical studies of recombinant factor IX
SEMINARS IN HEMATOLOGY